T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.11B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.59B |
| 3 |
EQT Corp
EQT
|
+$1.31B |
| 4 |
Colgate-Palmolive
CL
|
+$1.08B |
| 5 |
Adobe
ADBE
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.92B |
| 2 |
UnitedHealth
UNH
|
+$1.78B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.55B |
| 4 |
Ross Stores
ROST
|
+$1.54B |
| 5 |
ASML
ASML
|
+$1.49B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.61% |
| 2 | Healthcare | 16.91% |
| 3 | Consumer Discretionary | 11.05% |
| 4 | Financials | 10.6% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Johnson Controls International
JCI
$92.2B
| $115M | 0.02% |
1,690,617
-7,977
| -0.5% | -$491K |
|
502
Kymera Therapeutics
KYMR
$9.5B
| $115M | 0.02% |
5,007,148
+340,467
| +7% | +$9.76M |
|
503
Ares Management
ARES
$32.5B
| $114M | 0.02% |
1,179,759
-322,900
| -21% | -$27.9M |
|
504
BioMarin Pharmaceuticals
BMRN
$13.4B
| $112M | 0.02% |
1,291,678
-2,369
| -0.2% | -$223K |
|
505
Packaging Corp of America
PKG
$22.9B
| $112M | 0.02% |
844,707
-169,031
| -17% | -$22.6M |
|
506
XP
XP
$8.03B
| $110M | 0.02% |
4,681,580
-5,769,510
| -55% | -$97.9M |
|
507
Vaxcyte
PCVX
$8.93B
| $109M | 0.02% |
2,192,382
+2,160,354
| +6,745% | +$102M |
|
508
Carlyle Group
CG
$17.5B
| $109M | 0.02% |
3,414,374
+358,317
| +12% | +$10.5M |
|
509
Banco Santander Chile
BSAC
$16B
| $108M | 0.02% |
5,754,042
-126,358
| -2% | -$2.35M |
|
510
Vornado Realty Trust
VNO
$7.44B
| $107M | 0.01% |
5,889,182
+1,426,192
| +32% | +$21M |
|
511
NovoCure
NVCR
$2.04B
| $106M | 0.01% |
2,545,465
-110,221
| -4% | -$6.84M |
|
512
Gartner
IT
$11B
| $105M | 0.01% |
301,080
+4,181
| +1% | +$1.36M |
|
|
CTLT
513
DELISTED
CATALENT, INC.
CTLT
| $105M | 0.01% |
2,424,065
+646,674
| +36% | +$28.4M |
|
|
WWE
514
DELISTED
World Wrestling Entertainment
WWE
| $105M | 0.01% |
968,565
+302,166
| +45% | +$31.3M |
|
515
Relay Therapeutics
RLAY
$4.42B
| $105M | 0.01% |
8,345,517
+1,482,557
| +22% | +$18.4M |
|
516
Wynn Resorts
WYNN
$10.5B
| $105M | 0.01% |
991,829
-4,993,934
| -83% | -$535M |
|
517
Paychex
PAYX
$43.1B
| $105M | 0.01% |
936,298
-1,286
| -0.1% | -$141K |
|
518
Idexx Laboratories
IDXX
$44.4B
| $104M | 0.01% |
208,020
+34,108
| +20% | +$16.3M |
|
519
Inspire Medical Systems
INSP
$1.67B
| $103M | 0.01% |
317,120
+23,925
| +8% | +$6.84M |
|
520
Acadia Realty Trust
AKR
$2.85B
| $103M | 0.01% |
7,123,798
+279,187
| +4% | +$3.77M |
|
521
News Corp Class B
NWS
$17.7B
| $102M | 0.01% |
5,185,697
+443,121
| +9% | +$8.11M |
|
522
Denali Therapeutics
DNLI
$4.03B
| $102M | 0.01% |
3,445,312
-92,466
| -3% | -$2.6M |
|
523
Churchill Downs
CHDN
$6.14B
| $101M | 0.01% |
726,489
+21,315
| +3% | +$2.92M |
|
524
PayPal
PYPL
$50.9B
| $101M | 0.01% |
1,508,978
-26,610
| -2% | -$1.81M |
|
525
Duke Energy
DUK
$96.9B
| $100M | 0.01% |
1,119,370
+450
| +0% | +$42.5K |
|
Similar funds
T. Rowe Price Associates's Q2 2023 Portfolio in Review
As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
- T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
- T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
- T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
- T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
- T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.
Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.